drugset / Trial / NCT04129216

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

NCT04129216

Phase 2 Completed 30 enrolled Johns Hopkins University Agendia · collab
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The investigators would like to study the genetic and molecular outcomes that results after a short term neoadjuvant hormonal therapy on patients with breast cancer.

Timeline

Start
2019-02-20
Primary completion
2022-11-10
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Exemestane Small molecule 25 mg
Subject Letrozole Other / unclassified 2.5 mg
Subject Tamoxifen Small molecule 10 mg

Indications